Particularly, in B-cell lymphomas and T-cell leukemias, RASGRP1 and CRAF, two HSP90 client proteins, are degraded upon HDAC6 inhibition, leading to RASGRP1/CRAF-dependent apoptosis [124]. The gene discussed is RAF1; the disease is B-cell non-Hodgkin lymphoma.